Selected article for: "anti inflammatory effect and inhibitory effect"
Author: Mahgoub, Shahenda; Kotb El-Sayed, Mohamed-I; El-Shehry, Mohamed F.; Mohamed Awad, Samir; Mansour, Yara E.; Fatahala, Samar S.
Title: Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19
  • Cord-id: ajfaacnq
  • Document date: 2021_8_24
    • ID: ajfaacnq
    Snippet: Hypertension has been recognized as one of the most frequent comorbidities and risk factors for the seriousness and adverse consequences in COVID-19 patients. 3,4-dihydropyrimidin-2(1H) ones have attracted researchers to be synthesized via Beginilli reaction and evaluate their antihypertensive activities as bioisosteres of nifedipine a well-known calcium channel blocker. In this study, we report synthesis of some bioisosteres of pyrimidines as novel CCBs with potential ACE2 inhibitory effect as
    Document: Hypertension has been recognized as one of the most frequent comorbidities and risk factors for the seriousness and adverse consequences in COVID-19 patients. 3,4-dihydropyrimidin-2(1H) ones have attracted researchers to be synthesized via Beginilli reaction and evaluate their antihypertensive activities as bioisosteres of nifedipine a well-known calcium channel blocker. In this study, we report synthesis of some bioisosteres of pyrimidines as novel CCBs with potential ACE2 inhibitory effect as antihypertensive agents with protective effect against COVID-19 infection by suppression of ACE2 binding to SARS-CoV-2 Spike RBD. All compounds were evaluated for their antihypertensive and calcium channel blocking activities using nifedipine as a reference standard. Furthermore, they were screened for their ACE2 inhibition potential in addition to their anti‐inflammatory effects on LPS-stimulated THP‐1 cells. Most of the tested compounds exhibited significant antihypertensive activity, where compounds 7a, 8a and 9a exhibited the highest activity compared to nifedipine. Moreover, compounds 4a,b, 5a,b, 7a,b, 8a,c and 9a showed promising ACE2:SARS-CoV-2 Spike RBD inhibitory effect. Finally, compounds 5a, 7b and 9a exerted a promising anti-inflammatory effect by inhibition of CRP and IL-6 production. Ultimately, compound 9a may be a promising antihypertensive candidate with anti-inflammatory and potential efficacy against COVID-19 via ACE2 receptor inhibition.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid provide: 1
    • absence presence and activate cell: 1, 2
    • absence presence and activity decrease: 1
    • absence presence and activity duration: 1
    • absence presence and activity study: 1, 2, 3, 4, 5, 6, 7
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute phase protein: 1
    • absence presence and long duration: 1, 2
    • absence presence and lopinavir ritonavir: 1, 2
    • absence presence and low effect: 1
    • absence presence and low toxicity: 1, 2
    • absence presence and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6
    • absence presence and lps treatment: 1, 2
    • ace induce and lopinavir ritonavir: 1